Massachusetts General Hospital-ko ikertzaileekin lankidetzan egindako argitalpenak (8)

2024

  1. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

    Journal of Extracellular Vesicles, Vol. 13, Núm. 2

2019

  1. Yin-Yang 1 transcription factor modulates ST2 expression during adverse cardiac remodeling post-myocardial infarction

    Journal of Molecular and Cellular Cardiology, Vol. 130, pp. 216-233

2018

  1. Pulmonary Production of Soluble ST2 in Heart Failure

    Circulation. Heart failure, Vol. 11, Núm. 12, pp. e005488

2015

  1. Mineralocorticoid receptor antagonists modulate galectin-3 and interleukin-33/ST2 signaling in left ventricular systolic dysfunction after acute myocardial infarction

    JACC: Heart Failure, Vol. 3, Núm. 1, pp. 50-58

2014

  1. Galectin-3 expression in cardiac remodeling after myocardial infarction

    International Journal of Cardiology, Vol. 172, Núm. 1

  2. Modulation of IL-33/ST2 system in postinfarction heart failure: Correlation with cardiac remodelling markers

    European Journal of Clinical Investigation, Vol. 44, Núm. 7, pp. 643-651

2012

  1. Red blood cell distribution width predicts new-onset anemia in heart failure patients

    International Journal of Cardiology, Vol. 160, Núm. 3, pp. 196-200

2011

  1. Soluble ST2 is a marker for acute cardiac allograft rejection

    Annals of Thoracic Surgery, Vol. 92, Núm. 6, pp. 2118-2124